Stockreport

Mitsubishi Tanabe Pharma America Presents New Results of RADICAVA® (edaravone) for People Living with ALS at the European Network to Cure ALS (ENCALS) Meeting 2024 [Yahoo! Finance]

MITSUBISHI CH GRP U/ADR  (MTLHY) 
NASDAQ:AMEX Investor Relations: mitsubishichem-hd.co.jp/english/ir
PDF No new safety concerns in final results from long-term Phase 3 safety extension study in RADICAVA ORS ® (edaravone) JERSEY CITY, N.J. June 17, 2024 /PRNewswire/ -- Mi [Read more]